Form 8-K - Current report:
SEC Accession No. 0001558370-25-000075
Filing Date
2025-01-08
Accepted
2025-01-08 17:10:17
Documents
15
Period of Report
2025-01-03
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K pmn-20250103x8k.htm   iXBRL 8-K 36917
  Complete submission text file 0001558370-25-000075.txt   199845

Data Files

Seq Description Document Type Size
2 EX-101.SCH pmn-20250103.xsd EX-101.SCH 4363
3 EX-101.DEF pmn-20250103_def.xml EX-101.DEF 2869
4 EX-101.LAB pmn-20250103_lab.xml EX-101.LAB 12904
5 EX-101.PRE pmn-20250103_pre.xml EX-101.PRE 12251
17 EXTRACTED XBRL INSTANCE DOCUMENT pmn-20250103x8k_htm.xml XML 4994
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Filer) CIK: 0001374339 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41429 | Film No.: 25519268
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)